Combination immunotherapy shows potential in advanced melanoma clinical trial.

The Royal Marsden Hospital in the UK recently announced that a clinical trial showed that among patients with advanced melanoma who received combination treatment with two immunotherapies, nearly 30% had their tumors completely disappear on imaging scans. This result offers new ideas for improving the treatment of advanced melanoma.